| Cheryl Guyan, | |
|
150 W University Blvd, Melbourne, FL 32901-8995 | |
| (321) 674-8078 | |
| (321) 725-5967 |
| Full Name | Cheryl Guyan |
|---|---|
| Gender | Female |
| Speciality | Nurse Practitioner - Family |
| Location | 150 W University Blvd, Melbourne, Florida |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1174905020 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 163W00000X | Registered Nurse | RN9332284 (Florida) | Secondary |
| 363LF0000X | Nurse Practitioner - Family | ARNP 9332284 (Florida) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Cheryl Guyan, 150 W University Blvd, Melbourne, FL 32901-8995 Ph: (321) 674-8078 | Cheryl Guyan, 150 W University Blvd, Melbourne, FL 32901-8995 Ph: (321) 674-8078 |
News Archive
Hesperos Inc., pioneers of the "human-on-a-chip" in vitro system has announced the use of its innovative multi-organ model to successfully measure the concentration and metabolism of two known cardiotoxic small molecules over time, to accurately describe the drug behavior and toxic effects in vivo.
The Republican majority in the House, with President Obama's support, plans to scale back health care subsidies for the uninsured in order to pay for eliminating the "burdensome" requirement that small businesses file 1099 forms with the Internal Revenue Service when contractors are paid over $600.
Exclusive licenses to gene patents, most of which are held by academic institutions and based on taxpayer-funded research, do more to block competition in the gene testing market than to spur the development of new technologies for gauging disease risk, say researchers at the Duke Institute for Genome Sciences & Policy (IGSP).
Elusys Therapeutics, Inc. (Elusys), a biopharmaceutical company developing antibody therapies to treat infectious disease, presented data demonstrating that obiltoxaximab (ETI-204) demonstrated a statistically significant survival benefit across a range of disease severity in animal model studies assessing treatment of inhalational anthrax, as well as effectiveness in post-exposure prophylaxis.
› Verified 3 days ago
Mrs. Dawn P Hamel, ARNP-C Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 2290 W Eau Gallie Blvd, Melbourne, FL 32935 Phone: 321-435-1505 Fax: 321-426-7446 | |
Mrs. Stephanie Louise Battaglini, ARNP-C Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 1350 Hickory St Ste 102, Melbourne, FL 32901 Phone: 321-434-3452 Fax: 321-434-3456 | |
Mr. Donald Lee Hulen, ARNP Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 1350 Hickory St, Melbourne, FL 32901 Phone: 321-434-7243 | |
Mrs. Nicole Wiggins, NP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 1314 Oak St, Melbourne, FL 32901 Phone: 321-727-7992 Fax: 321-727-7664 | |
Tiffani Davidson, APRN, DNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 1223 Gateway Dr Ste 2e, Melbourne, FL 32901 Phone: 321-361-5564 | |
William Brandon Evans, FNP Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 1350 Hickory St, Melbourne, FL 32901 Phone: 321-434-1771 | |
Stacyann Stephens, Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 2626 Florencia Pl, Melbourne, FL 32940 Phone: 305-338-5141 |